Investigation of relationship between plasma gamma-glutamyl transferase concentrations with metabolic syndrome

  • Nguyen Cam Thach 108 Military Central Hospital
  • Dam Thi Huyen Thanh 108 Military Central Hospital
  • Nguyen Van Tuyen 108 Military Central Hospital
  • Dinh Thi Thao 108 Military Central Hospital

Main Article Content

Keywords

Metabolic syndrome, gamma-glutamyl transferase, 108 Military Central Hospital

Abstract

Objective: To investigate the relationship between plasma gamma-glutamyl transferase concentrations and metabolic syndrome (MS) at 108 Military Central Hospital. Subject and method: A prospective cross-sectional study was conducted on 104 participants with MS and 108 participants without MS, examining at Department of Examination - 108 Military Central Hospital from 01/11/2020 to 30/04/2021. Result: The plasma GGT levels of patients with MS (59.83 ± 47.9U/L) were higher than those in group without MS (42.09 ± 18.21U/L), p<0.05. Compared to normal GGT level, the odds ratio was 1.03 (95% CI: 1.26 to 2.05), p<0.05 and 2.14 (95% CI 1.33 to 6.05), p<0.001 with increasing GGT levels (GGT > 61 - 122U/l and GGT > 122U/l), respectively. Conclusion: The GGT levels in plasma of patients with MS (59.83 ± 47.9U/L) were higher than those of patients without MS (42.09 ± 18.21U/L), p<0.05. Raising plasma GGT concentrations was positively associated with MS presence (OR = 2.715, 95% CI: 1.406 - 5.246, p<0.05).

Article Details

References

1. Eckel RH, PZ Grundy Sm Fau - Zimmet, and Zimmet PZ (2005) The metabolic syndrome. Lancet 365(1474-547X (Electronic)): 1415-1428.
2. Grundy SM et al (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28(1524-4636 (Electronic)): 629-636.
3. Whitfield JB et al (2001) Gamma glutamyl transferase. Critical Reviews in Clinical Laboratory Sciences 38(4)(1040-8363): 263-355.
4. Kasapoglu B et al (2010) Role of GGT in diagnosis of metabolic syndrome: A clinic-based cross-sectional survey. Indian J Res Med 132(0971-5916): 56-61.
5. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome-a new world wide definition. Lancet 366: 1059-1062. DOI: 10.1016/S0140-6736(05)67402-8.
6. Pucci G et al (2017) Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol Res 120: 34-42.
7. Lee JG et al (2009) Multiple biomarkers and their relative contributions to identifying metabolic syndrome. Clinica Chimica Acta, 408(1873-3492 (Electronic)): 50-55.
8. Lee DS et al (2007) Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 27(1)(1524-4636 (Electronic)): 127-133.
9. Liu CF et al (2012) Gamma-glutamyltransferase level and risk of hypertension: A systematic review and meta-analysis. Plos one 7(11): e48878. doi: 10.1371/journal.pone.0048878.

Article Sidebar

PDF (Tiếng Việt)
Published
Jul 15, 2021
DOI: https://doi.org/10.52389/ydls.v16i5.824
Issue
Volume 16 - No 5/2021
Section
Articles
How to Cite
ThachN. C., ThanhD. T. H., TuyenN. V., & ThaoD. T. (2021). Investigation of relationship between plasma gamma-glutamyl transferase concentrations with metabolic syndrome . Tạp Chí Y Dược lâm sàng 108, 16(5). https://doi.org/10.52389/ydls.v16i5.824